Geode Capital Management
FRTX

Geode Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Geode Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-41,449
Closed -$40.2K – 4725
2023
Q3 		$40.2K Buy
41,449
+26,801
+183% +$18.9K ﹤0.01% 4469
2023
Q2 		$10.3K Hold
14,648
– – ﹤0.01% 4714
2023
Q1 		$9.67K Sell
14,648
-201
-1% -$335 ﹤0.01% 4765
2022
Q4 		$21K Hold
14,849
– – ﹤0.01% 4761
2022
Q3 		$26K Buy
+14,849
New +$43K ﹤0.01% 4878
2022
Q2 		– Sell
-13,940
Closed -$167K – 5043
2022
Q1 		$167K Hold
13,940
– – ﹤0.01% 4463
2021
Q4 		$143K Hold
13,940
– – ﹤0.01% 4614
2021
Q3 		$451K Buy
13,940
+1,422
+11% +$46.1K ﹤0.01% 4079
2021
Q2 		$535K Buy
12,518
+671
+6% +$27.6K ﹤0.01% 3914
2021
Q1 		$581K Buy
11,847
+7,403
+167% +$407K ﹤0.01% 3752
2020
Q4 		$156K Buy
4,444
+4,089
+1,152% +$128K ﹤0.01% 3956
2020
Q3 		$14K Hold
355
– – ﹤0.01% 4136
2020
Q2 		$15K Hold
355
– – ﹤0.01% 4081
2020
Q1 		$18K Hold
355
– – ﹤0.01% 4045
2019
Q4 		$23K Hold
355
– – ﹤0.01% 4148
2019
Q3 		$66K Hold
355
– – ﹤0.01% 4031
2019
Q2 		$94K Hold
355
– – ﹤0.01% 3973
2019
Q1 		$134K Hold
355
– – ﹤0.01% 3835
2018
Q4 		$131K Hold
355
– – ﹤0.01% 3807
2018
Q3 		$153K Hold
355
– – ﹤0.01% 3830
2018
Q2 		$128K Hold
355
– – ﹤0.01% 3825
2018
Q1 		$161K Hold
355
– – ﹤0.01% 3741
2017
Q4 		$204K Buy
355
+235
+196% +$155K ﹤0.01% 3667
2017
Q3 		$90K Hold
120
– – ﹤0.01% 3843
2017
Q2 		$102K Sell
120
-6
-5% -$4.39K ﹤0.01% 3841
2017
Q1 		$88K Buy
126
+1
+0.8% +$705 ﹤0.01% 3849
2016
Q4 		$90K Hold
125
– – ﹤0.01% 3806
2016
Q3 		$119K Buy
125
+1
+0.8% +$1.26K ﹤0.01% 3767
2016
Q2 		$177K Buy
124
+22
+22% +$28.3K ﹤0.01% 3630
2016
Q1 		$125 Hold
102
– – ﹤0.01% 3774
2015
Q4 		$132K Hold
102
– – ﹤0.01% 3815
2015
Q3 		$147K Hold
102
– – ﹤0.01% 3782
2015
Q2 		$224K Buy
102
+3
+3% +$9.41K ﹤0.01% 3544
2015
Q1 		$295K Hold
99
– – ﹤0.01% 3431
2014
Q4 		$327K Hold
99
– – ﹤0.01% 3378
2014
Q3 		$349K Sell
99
-2
-2% -$7.77K ﹤0.01% 3328
2014
Q2 		$387K Sell
101
-13
-11% -$48.9K ﹤0.01% 3274
2014
Q1 		$461K Buy
114
+20
+21% +$89.3K ﹤0.01% 3183
2013
Q4 		$350K Buy
94
+1
+1% +$3.79K ﹤0.01% 3232
2013
Q3 		$366K Buy
93
+3
+3% +$22.5K ﹤0.01% 3086
2013
Q2 		$890K Buy
+90
New +$997K ﹤0.01% 2531

Other funds holding FRTX

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Geode Capital Management's FRTX Position: Q4 2023 in Review

Geode Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 41,449 shares — an estimated $40.2K sold.

Geode Capital Management first reported a position in FRTX in Q2 2013 and held it in 41 quarters. The position peaked at $890K in Q2 2013. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.

  • Geode Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Geode Capital Management sold 41,449 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $40.2K.
  • Geode Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 41 quarters.
  • Geode Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $890K in Q2 2013.
  • 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.